Trial to Evaluate Efficacy and Safety of Apraglutide in SBS-IF

Clinical trial NCT04627025 · COMPLETED

Trial details

NCT number: NCT04627025
Sponsor: VectivBio AG
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Short Bowel Syndrome

Start date: 2021-01-26
Primary completion: 2024-01-02
Enrollment: 164

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.